These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 34256994

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease.
    McGlinchey AJ, Govaere O, Geng D, Ratziu V, Allison M, Bousier J, Petta S, de Oliviera C, Bugianesi E, Schattenberg JM, Daly AK, Hyötyläinen T, Anstee QM, Orešič M.
    JHEP Rep; 2022 May; 4(5):100477. PubMed ID: 35434590
    [Abstract] [Full Text] [Related]

  • 3. Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis.
    Ooi GJ, Meikle PJ, Huynh K, Earnest A, Roberts SK, Kemp W, Parker BL, Brown W, Burton P, Watt MJ.
    J Hepatol; 2021 Sep; 75(3):524-535. PubMed ID: 33887358
    [Abstract] [Full Text] [Related]

  • 4. Lipidomic identification of urinary extracellular vesicles for non-alcoholic steatohepatitis diagnosis.
    Zhu Q, Li H, Ao Z, Xu H, Luo J, Kaurich C, Yang R, Zhu PW, Chen SD, Wang XD, Tang LJ, Li G, Huang OY, Zheng MH, Li HP, Liu F.
    J Nanobiotechnology; 2022 Jul 27; 20(1):349. PubMed ID: 35897102
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polyunsaturated fatty acid metabolites as novel lipidomic biomarkers for noninvasive diagnosis of nonalcoholic steatohepatitis.
    Loomba R, Quehenberger O, Armando A, Dennis EA.
    J Lipid Res; 2015 Jan 27; 56(1):185-92. PubMed ID: 25404585
    [Abstract] [Full Text] [Related]

  • 8. Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study.
    Perakakis N, Polyzos SA, Yazdani A, Sala-Vila A, Kountouras J, Anastasilakis AD, Mantzoros CS.
    Metabolism; 2019 Dec 27; 101():154005. PubMed ID: 31711876
    [Abstract] [Full Text] [Related]

  • 9. The plasma lipidomic signature of nonalcoholic steatohepatitis.
    Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ.
    Hepatology; 2009 Dec 27; 50(6):1827-38. PubMed ID: 19937697
    [Abstract] [Full Text] [Related]

  • 10. Natural History of Simple Steatosis or Nonalcoholic Fatty Liver.
    De A, Duseja A.
    J Clin Exp Hepatol; 2020 Dec 27; 10(3):255-262. PubMed ID: 32405182
    [Abstract] [Full Text] [Related]

  • 11. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
    Aida Y, Abe H, Tomita Y, Nagano T, Seki N, Sugita T, Itagaki M, Ishiguro H, Sutoh S, Aizawa Y.
    Int J Clin Exp Med; 2014 Dec 27; 7(11):4191-8. PubMed ID: 25550930
    [Abstract] [Full Text] [Related]

  • 12. Nonalcoholic fatty liver disease stratification by liver lipidomics.
    Vvedenskaya O, Rose TD, Knittelfelder O, Palladini A, Wodke JAH, Schuhmann K, Ackerman JM, Wang Y, Has C, Brosch M, Thangapandi VR, Buch S, Züllig T, Hartler J, Köfeler HC, Röcken C, Coskun Ü, Klipp E, von Schoenfels W, Gross J, Schafmayer C, Hampe J, Pauling JK, Shevchenko A.
    J Lipid Res; 2021 Dec 27; 62():100104. PubMed ID: 34384788
    [Abstract] [Full Text] [Related]

  • 13. Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies.
    Reddy YK, Marella HK, Jiang Y, Ganguli S, Snell P, Podila PSB, Maliakkal B, Satapathy SK.
    J Clin Exp Hepatol; 2020 Dec 27; 10(3):245-254. PubMed ID: 32405181
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H, Zhu X, Xia M, Yan H, Chang X, Hu X, Pan B, Guo W, Li X, Gao X.
    Endocr Pract; 2020 Apr 27; 26(4):444-453. PubMed ID: 31968197
    [Abstract] [Full Text] [Related]

  • 17. The promising role of CCL2 as a noninvasive marker for nonalcoholic steatohepatitis diagnosis in Egyptian populations.
    Ali AA, Fouda A, Abdelaziz ES, Abdelkawy K, Ahmed MH.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e954-e960. PubMed ID: 34907983
    [Abstract] [Full Text] [Related]

  • 18. A lipidomic analysis of nonalcoholic fatty liver disease.
    Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, Sargeant C, Contos MJ, Sanyal AJ.
    Hepatology; 2007 Oct 01; 46(4):1081-90. PubMed ID: 17654743
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.
    Fujii Y, Nouso K, Matsushita H, Kariyama K, Sakurai T, Takahashi Y, Chiba H, Hui SP, Ito Y, Ohta M, Okada H.
    J Appl Lab Med; 2020 Nov 01; 5(6):1206-1215. PubMed ID: 32674154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.